Advancing Pipeline of Diversified Cell Therapies in Oncology
Our CAR-T Platform
Inceptor Bio's OutlasT platform is designed to exhibit desirable attributes for effective solid tumor control, including endurance in the hostile tumor microenvironment, durability, and fitness.
Our CAR-M Platform
Inceptor Bio’s CAR-M platform is built to improve tumor infiltration, improve phagocytosis ability, and potentiate immune cascade.
Our CAR-NK Platform
Inceptor Bio's CAR-NK platform is designed to enhance cytotoxicity, improve persistence, and drive disruption othe TME. We are collaborating with a leading academic university to develop iPSC derived CAR-NK.
